Document Detail


Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
MedLine Citation:
PMID:  18801929     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The receptors for IGF-I (IGF-IR) and insulin (IR) have been implicated in physiological cardiac growth, but it is unknown whether IGF-IR or IR signaling are critically required. We generated mice with cardiomyocyte-specific knockout of IGF-IR (CIGF1RKO) and compared them with cardiomyocyte-specific insulin receptor knockout (CIRKO) mice in response to 5 wk exercise swim training. Cardiac development was normal in CIGF1RKO mice, but the hypertrophic response to exercise was prevented. In contrast, despite reduced baseline heart size, the hypertrophic response of CIRKO hearts to exercise was preserved. Exercise increased IGF-IR content in control and CIRKO hearts. Akt phosphorylation increased in exercise-trained control and CIRKO hearts and, surprisingly, in CIGF1RKO hearts as well. In exercise-trained control and CIRKO mice, expression of peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) and glycogen content were both increased but were unchanged in trained CIGF1RKO mice. Activation of AMP-activated protein kinase (AMPK) and its downstream target eukaryotic elongation factor-2 was increased in exercise-trained CIGF1RKO but not in CIRKO or control hearts. In cultured neonatal rat cardiomyocytes, activation of AMPK with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) prevented IGF-I/insulin-induced cardiomyocyte hypertrophy. These studies identify an essential role for IGF-IR in mediating physiological cardiomyocyte hypertrophy. IGF-IR deficiency promotes energetic stress in response to exercise, thereby activating AMPK, which leads to phosphorylation of eukaryotic elongation factor-2. These signaling events antagonize Akt signaling, which although necessary for mediating physiological cardiac hypertrophy, is insufficient to promote cardiac hypertrophy in the absence of myocardial IGF-I signaling.
Authors:
Jaetaek Kim; Adam R Wende; Sandra Sena; Heather A Theobald; Jamie Soto; Crystal Sloan; Benjamin E Wayment; Sheldon E Litwin; Martin Holzenberger; Derek LeRoith; E Dale Abel
Related Documents :
15292739 - Effects of oat beta-glucan on innate immunity and infection after exercise stress.
19144689 - Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progres...
23349859 - Passive exercise of the hind limbs after complete thoracic transection of the spinal co...
10712579 - Immunomodulation by 8-week voluntary exercise in mice.
23175179 - Cardiac work remains high after strength exercise in elderly.
20300909 - Physical exercise attenuates mptp-induced deficits in mice.
11719889 - Nycthemeral variations in core temperature and heart rate: continuous cycling exercise ...
1429249 - A comparison of changes in the stereocilia between temporary and permanent hearing loss...
3631199 - Reduction of asthenopia after accommodative facility training.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2008-09-18
Journal Detail:
Title:  Molecular endocrinology (Baltimore, Md.)     Volume:  22     ISSN:  0888-8809     ISO Abbreviation:  Mol. Endocrinol.     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-10-28     Completed Date:  2009-06-11     Revised Date:  2011-05-05    
Medline Journal Info:
Nlm Unique ID:  8801431     Medline TA:  Mol Endocrinol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2531-43     Citation Subset:  IM    
Affiliation:
Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, Utah 84112, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
AMP-Activated Protein Kinases / metabolism
Aminoimidazole Carboxamide / analogs & derivatives,  pharmacology
Animals
Cardiomegaly / etiology*,  pathology,  physiopathology*
Cell Enlargement / drug effects
Cells, Cultured
Male
Mice
Mice, Knockout
Models, Cardiovascular
Myocardial Contraction
Myocytes, Cardiac / cytology,  drug effects,  metabolism
Peptide Elongation Factor 2 / metabolism
Physical Exertion
Proto-Oncogene Proteins c-akt / metabolism
Rats
Receptor, IGF Type 1 / deficiency,  genetics,  physiology*
Receptor, Insulin / deficiency,  genetics,  physiology
Ribonucleotides / pharmacology
Signal Transduction
Swimming
Grant Support
ID/Acronym/Agency:
5T32 HL007576/HL/NHLBI NIH HHS; R01 DK092065-07/DK/NIDDK NIH HHS; R01HL070070/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Peptide Elongation Factor 2; 0/Ribonucleotides; 3031-94-5/AICA ribonucleotide; 360-97-4/Aminoimidazole Carboxamide; EC 2.7.10.1/Receptor, IGF Type 1; EC 2.7.10.1/Receptor, Insulin; EC 2.7.11.1/AMP-Activated Protein Kinases; EC 2.7.11.1/Proto-Oncogene Proteins c-akt
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Volcanic sulfur dioxide and acute respiratory symptoms on Miyakejima island.
Next Document:  Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate a...